PMC:7278327 / 795-1099 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T8","span":{"begin":187,"end":190},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma55675"}],"text":"esized that a similar mechanism exists to explain the multiple neurological effects of SARS-CoV-2 via binding to peripheral nAChRs followed by orthograde or retrograde transport into the CNS. Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV "}

{"project":"LitCovid-PubTator","denotations":[{"id":"36","span":{"begin":87,"end":97},"obj":"Species"},{"id":"41","span":{"begin":219,"end":223},"obj":"Species"},{"id":"42","span":{"begin":299,"end":303},"obj":"Species"}],"attributes":[{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"Tax:2697049"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"Tax:11292"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"Tax:11292"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"esized that a similar mechanism exists to explain the multiple neurological effects of SARS-CoV-2 via binding to peripheral nAChRs followed by orthograde or retrograde transport into the CNS. Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":87,"end":95},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"esized that a similar mechanism exists to explain the multiple neurological effects of SARS-CoV-2 via binding to peripheral nAChRs followed by orthograde or retrograde transport into the CNS. Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":12,"end":13},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T15","span":{"begin":187,"end":190},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T16","span":{"begin":187,"end":190},"obj":"http://www.ebi.ac.uk/efo/EFO_0000908"},{"id":"T17","span":{"begin":224,"end":227},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"esized that a similar mechanism exists to explain the multiple neurological effects of SARS-CoV-2 via binding to peripheral nAChRs followed by orthograde or retrograde transport into the CNS. Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T4","span":{"begin":168,"end":177},"obj":"http://purl.obolibrary.org/obo/GO_0006810"}],"text":"esized that a similar mechanism exists to explain the multiple neurological effects of SARS-CoV-2 via binding to peripheral nAChRs followed by orthograde or retrograde transport into the CNS. Genetic engineering of the RABV has been employed to generate novel vaccines consisting of non-replicating RABV "}